Delve into Roche's strategy, a company originally built on oncology, now reinventing its pipeline in obesity and immunology.

Delve into bronchiectasis, a field long focused on managing symptoms that now has its first targeted treatment with ...

Discover Prague's biotech hub, now viewed as the primary ‘entry gateway’ into the wider Central and Eastern European biopharma market.

Biotech and biopharma companies choose names that cluster around certain letters in the alphabet - here's what they are, and ...

Discover why animal models fall short in AI drug discovery and how human-first datasets and functional genomics are changing ...

Despite decades of progress in oncology, the majority of cancer drugs that enter clinical trials never reach the market and the patients who need them most. Late-stage failure remains one of the most ...

Home to the European Commission (EC), Belgium holds a reputation for life sciences and innovation in Europe. In the port city of Ghent, the Vlaams Instituut voor Biotechnologie (VIB) wants to bridge ...

With one of the most densely concentrated life sciences and biotech ecosystems in Europe, the Netherlands is home to numerous biotech and pharmaceutical companies, and also happens to be the ...

A kind of immunotherapy, cancer vaccines have been around since the link between human papillomavirus (HPV) and cancer was discovered in the 1980s. For the prevention of cancers caused by the virus, ...

The OECD recently published an update on key biotechnology indicators, an opportunity for us to delve into the top-performing countries in the field. With the highest number of active biotech ...

Last year, we took a look at the biotech trends that we thought would shape 2024. Now, as we enter the new year, the biotech industry is continuing to evolve at a rapid pace, and 2025 is shaping up to ...